Australia markets closed

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.12+0.13 (+0.19%)
At close: 4:00PM EDT

Hologic, Inc.

250 Campus Drive
Marlborough 01752
United States
508 263 2900
http://www.hologic.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees6,478

Key executives

NameTitlePayExercisedYear born
Mr. Stephen P. MacMillanChairman, CEO & Pres3.27M5.74M1964
Ms. Karleen M. ObertonChief Financial Officer1.06MN/A1970
Mr. John M. GriffinGen. Counsel1.12MN/A1961
Mr. Peter J. Valenti IIIDivision Pres of Breast & Skeletal Health1.19M196.63k1963
Mr. Kevin R. ThornalDivision Pres of Diagnostic Solutions1.89MN/A1974
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Corporate governance

Hologic, Inc.’s ISS governance QualityScore as of 8 December 2019 is 6. The pillar scores are Audit: 1; Board: 2; Shareholder rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.